The neurocognitive performance of drug-free and medicated euthymic bipolar patients do not differ

Acta Psychiatrica Scandinavica

Volumn 120, Issue 6, 2009, Pages 456-463

  Goswami, U ^a,b,c   Sharma, A ^a,c   Varma, A ^a,d   Gulrajani, C ^a,e   Ferrier, I N ^c   Young, A H ^c,f   Gallagher, P ^c   Thompson, J M ^c   Moore, P B ^c  

^a LADY HARDINGE MEDICAL COLLEGE   (India)

^b The Royal College of Psychiatrists   (United Kingdom)

^c NEWCASTLE UNIVERSITY   (United Kingdom)

^d EDWARD VIA COLLEGE OF OSTEOPATHIC MEDICINE   (United States)

^e YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Bipolar disorder; Cognitive impairment; Neuropsychology; Psychopharmacology

Indexed keywords

CARBAMAZEPINE; LITHIUM; PROPRANOLOL; SEROTONIN UPTAKE INHIBITOR; VALPROIC ACID;

ADULT; ANALYSIS OF COVARIANCE; ARTICLE; ATTENTION; BIPOLAR I DISORDER; CLINICAL ARTICLE; COGNITIVE DEFECT; CONTROLLED STUDY; CORRELATION ANALYSIS; DEPRESSION; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DISEASE SEVERITY; DRUG EFFECT; EFFECT SIZE; FEMALE; HAMILTON SCALE; HUMAN; LEARNING; MALE; MEMORY; MONOTHERAPY; MOOD; NEUROPSYCHOLOGICAL TEST; NEUROPSYCHOLOGY; PERSEVERATION; PRIORITY JOURNAL; PSYCHOPHARMACOLOGY; QUALITY OF LIFE; VERBAL MEMORY;

ANTIMANIC AGENTS; ATTENTION; BIPOLAR DISORDER; COGNITION; EXECUTIVE FUNCTION; FEMALE; HUMANS; MALE; MEMORY; NEUROPSYCHOLOGICAL TESTS; PROPRANOLOL; PSYCHIATRIC STATUS RATING SCALES; SEROTONIN UPTAKE INHIBITORS;

EID: 70449435377     PISSN: 0001690X     EISSN: 16000447     Source Type: Journal    
DOI: 10.1111/j.1600-0447.2009.01390.x     Document Type: Article

References (31)

1. Martinez-Aran A, Vieta E, Rei Nares M et al. Cognitive function across manic or hypomanic depressed, and euthymic states in bipolar disorder. Am J Psychiatry 2004 161 : 262 270.
2. Ferrier IN, Thompson JM. Cognitive impairment in bipolar affective disorder: implications for the bipolar diathesis. Br J Psychiatry 2002 180 : 293 295.
3. Goswami U, Sharma A, Khastgir U et al. Neuropsychological dysfunction, soft neurological signs and social disability in euthymic patients with bipolar disorder. Br J Psychiatry 2006 188 : 366 373.
4. Clark L, Iversen SD, Goodwin GM. Sustained attention deficit in bipolar disorder. Br J Psychiatry 2002 180 : 313 319.
5. Cavanagh JTO, Van Beck M, Muir W, Blackwood DHR. Case-controlled study of neurocognitive function in euthymic patients with bipolar disorder: an association with mania. Br J Psychiatry 2002 180 : 320 326.
6. Rubinstein JS, Michael A, Paykel ES, Sahakian BJ. Cognitive impairment in remission in bipolar affective disorder. Psychol Med 2000 30 : 1025 1036.
7. Lezak MD, Howieson DB, Loring DW. Neuropsychological assessment, 4th edn. New York : Oxford University Press, 2004.
8. Devinsky O. Cognitive and behavioural effects of antiepileptic drugs. Epilepsia 1995 36 (suppl. 2 S46 S65.
9. Honig A, Arrts BMG, Ponds RWHM, Riedel WJ. Lithium induced cognitive side effects in bipolar disorder: a quantitative analysis and implications for daily practice. Int Clin Psychopharmacol 1999 14 : 167 171.
10. Moore PB, Shepherd DJ, Eccleston D et al. Cerebral white matter lesions in bipolar affective disorder: relationship to outcome. Br J Psychiatry 2001 178 : 172 176.
11. Porter R, Gallagher P, Thompson JM, Young AH. Neurocognitive impairment in drug-free patients with major depressive disorder. Br J Psychiatry 2003 182 : 214 220.
12. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry 1960 23 : 56 62.
13. Bech P, Bolwig TG, Dein E, Jacobsen O, Gram LF. Quantitative rating of manic states. Acta Psychiatr Scand 1975 59 : 1 6.
14. American Psychiatric Association. Diagnostic and statistical manual of mental disorders, 4th edn. Washington, DC : American Psychiatric Association Press, 1994.
15. Strauss E, Sherman EMS, Spreen O. A compendium of neuropsychological test. administration, norms, and commentary. New York : Oxford University Press, 2006.
16. Rey A. L'examen clinique en psychologie. Paris : Presses Universitaire de France, 1964.
17. Wechsler D. WAIS-R manual. New York : The Psychological Corporation, 1981.
18. Diller L, Ben-Yishay Y, Gerstman LJ et al. Studies in cognition and rehabilitation in Hemiplegia (Rehabilitation Monograph No. 50). New York : New York University Medical Center, Institute of Rehabilitation Medicine, 1974.
19. Smith A. Symbol digit modalities test (SDMT). Manual (revised). Los Angeles, CA : Western Psychological Services, 1982.
20. Reiten RM. Validity of the Trail Making Test as an indicator of organic brain damage. Percept Mot Skills 1964 8 : 271 276.
21. Regard M. The perception and control of emotions: hemispheric differences and the role of the frontal lobes. Habilitationsschrift, Zurich : Department of Neurology, University Hospital, 1991.
22. Porteus D. Portous maze, fifty years' application. New York : Psychological Corporation, 1965.
23. Buchner A, Erdfelder E, Faul F, 1997. Available at: http://www.psycho. uni-dusseldorf.de/aap/projects/gpower
24. Gulrajani C. A study of the differential cognitive side-effects of mood stabilisers in euthymic patients with bipolar mood disorder. MD Thesis, New Delhi, India : University of Delhi, 2003.
25. Robinson LJ, Goswami U, Gallagher P et al. A meta-analysis of cognitive deficits in euthymic bipolar subjects. J Affect Disord 2006 93 : 105 115.
26. Torres IJ, Boudreau VG, Yatham LN. Neuropsychological functioning in euthymic bipolar disorder: a meta-analysis. Acta Psychiatr Scand 2007 116 (s 434 17 26.
27. Joffe RT, Macdonald C, Kutcher SP. Lack of differential cognitive effects of lithium and carbamazepine in bipolar affective disorder. J Clin Psychopharmacol 1988 8 : 42 45.
28. Engelsmann F, Katz J, Gharidian AM, Schchter D. Lithium and memory: a long-term follow-up. J Clin Psychopharmacol 1988 8 : 207 212.
29. Kocsis JH, Shaw ED, Stoker PE. Neuropsychologic effects of lithium discontinuation. J Clin Psychopharmacol 1993 13 : 268 275.
30. Mur M, Portella MJ, Martinez-Aran A, Pifarre′ J, Vieta E. Neuropsychological profile in bipolar disorder: a preliminary study of monotherapy lithium-treated euthymic bipolar patients evaluated at a 2-year interval. Acta Psychiatr Scand 2008 118 : 373 381.
31. Gualtieri CT, Johnson LG. Comparative neurocognitive effects of 5 psychotropic anticonvulsants and lithium. Med Gen Med 2006 8 : 46.